Ticker Details
IDEAYA Biosciences, Inc.
IPO Date:	May 20, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.52 | 2.88%
Avg Daily Range (30 D):	$0.77 | 2.28%
Avg Daily Range (90 D):	$0.71 | 2.18%

Institutional Daily Volume
Avg Daily Volume:	.43M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.77M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	2,692
Avg Institutional Trade:	$2.44M
Avg Institutional Trade (30 D):	$3.74M
Avg Institutional Trade (90 D):	$3.19M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.31M
Avg Closing Trade (30 D):	$5.83M
Avg Closing Trade (90 D):	$5.72M
Avg Closing Volume:	123.85K

News

Dec 17, 2025 @ 3:00 PM Antibody Optimization Service Market Set to Reach ... Source: Towards Healthcare

Oct 14, 2025 @ 5:00 PM Melanoma Clinical Trial Pipeline Accelerates as 15... Source: Delveinsight

Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai

Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight

Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.28	$-.94	$-1.28
Diluted EPS	$-1.28	$-.94	$-1.28
Revenue	$218.71M	$10.88M	$218.71M
Gross Profit
Net Income / Loss	$-113.7M	$-83.27M	$-113.7M
Operating Income / Loss	$-159.31M	$-94.57M	$-159.31M
Cost of Revenue
Net Cash Flow	$28.66M	$-185.89M	$28.66M
PE Ratio